Clinical Trials Browser

Phase NA × 177Lu-DOTA-JR11 × Clear all

NCT02609737 2022-02-01

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Phase NA Completed

20 enrolled 8 charts

Neuroendocrine Tumors